Today

Agents

Chat

Arena

Discover

More

App

CTT Pharmaceutical CEO Ryan Khouri acquires 10,900 common shares for $523.2 - CTTH News | Rallies

CTT Pharmaceutical CEO Ryan Khouri acquires 10,900 common shares for $523.2

CTTH•2026-09-16

CEO share purchase

CTT Pharmaceutical Holdings CEO Ryan Khouri reported an open-market purchase of 10,900 CTTH shares at $0.05 each.
His directly held stake increased to 9,414,456 shares following the purchase.

Related News

Pharvaris Chief Commercial Officer Wim Souverijns sells USD 1.02 million in common shares

PHVS•2026-09-16

Republican senator faults Trump vaccine policy for US measles deaths as panel weighs health nominees

XLV•2026-09-16

onsemi targets $213 billion market opportunity by 2030 with platform-based power and sensing strategy

Sources

S

CTT Pharmaceutical CEO Ryan Khouri acquires 10,900 common shares for $523.2

Sec

ON•2026-09-16

Nasdaq Trade Halt <DLXY.O> Volatility Trading Pause at 01:42 PM

DLXY•2026-09-16

Bessent says US open to discussing shared AI risks with China, Axios reports

SPY•2026-09-16